Biological disposition of boldine: In vitro and in vivo studies

Phytotherapy Research

Volumn 14, Issue 4, 2000, Pages 254-260

  Jiménez, Inés ^a   Speisky, Hernán ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Biological disposition; Boldine; Isolated hepatocytes; Perfused livers; Whole animal

Indexed keywords

BOLDINE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG LIVER LEVEL; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LIVER PERFUSION; LIVER PROTECTION; MALE; NONHUMAN; RAT;

ANIMALS; APORPHINES; LIVER; MALE; RATS; RATS, WISTAR;

ANIMALIA; APUS APUS;

EID: 0034050923     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1573(200006)14:4<254::AID-PTR582>3.0.CO;2-M     Document Type: Article

References (22)

1. Aruoma, O. I. (1998). Free radicals, oxidative stress, and antioxidants in human health and disease. J. Am. Oil Chem. Soc. 75(2), 199-212.
2. Backhouse, N., Del Porte, C., Givernau, M., Cassels, B., Valenzuela, A., and Speisky, H. (1994). Anti-inflammatory and anti-pyretic effects of boldine. Agents Actions 42, 114-117.
3. Bannach, R., Valenzuela, A., Cassels, B., Núñez-Vergara, L., and Speisky, H. (1996). Cytoprotective and antioxidant effects of boldine on tert-butyl-hydroperoxide-induced damage to isolated hepatocytes. Cell Biol. Toxicol. 12(2), 89-100.
4. Cederbaum, A. I., Kukielka, E., and Speisky, H. (1992). Inhibition of rat liver microsomal lipid peroxidation by boldine. Biochem. Pharmacol. 44(9), 1765-1772.
5. Genest, K., and Hughes, D. W. (1968). Natural products in Canadian pharmaceuticals. II. Peumus boldus. Can. J. Pharm. Sci. 3, 84-90.
6. González-Cabello, R., Speisky, H., Bannach, R., Valenzuela, A., Féher, J., and Gergely, P. (1994). Effects of boldine on cellular immune functions in vitro. J. Invest. Allergol. Clin. Immunol. 4(3), 139-145.
7. Gotteland, M., Jiménez, I., Brunser, O. et al. (1997). Protective effect of boldine in experimental colitis. Planta Med. 63, 311-315.
8. Halliwell, B. (1994). Free radicals and antioxidants. Nutr. Rev. 1, 253-265.
9. Kreitmair, H. (1952). Pharmakologische Wirkung des Alkaloids aus Peumus boldus Molina. Die Pharmazie 7, 507-511.
10. Kringstein, P., and Cederbaum, A. I. (1995). Boldine prevents liver microsomal lipid peroxidation and inactivation of cytochrome P4502E1. Free Rad. Biol. Med. 18(3), 559-563.
11. Lanhers, M. C., Joyeux, M., Soulimani, R. et al. (1991). Hepatoprotective and anti-inflammatory effects of a traditional medicinal plant of Chile, Peumus boldus. Plants Med. 57(2), 110-115.
12. Martínez, L. A., Ríos, J. L., Payá, M., and Alcaraz, M. J. (1992). Inhibition of non-enzymatic lipid peroxidation by benzylisoquinoline alkaloids. Free Rad. Biol. Med. 12, 287-292.
13. Moldeus, P., Hogberg, J., and Orrenius, S. (1978). In Methods in Enzymology, pp. 60-71, Academic Press, New York.
14. Otto, D. A., and Cook, G. A. (1983). In The Isolation, Characterisation, and Use of Hepatocytes, pp 44-48, Elsevier Science, New York.
15. Rowland, M., Benet, L. Z., and Graham, G. G. (1973). Clearance concepts in pharmacokinetics. J. Pharmacokinet. Biopharm. 1, 123-136.
16. Speisky, H., Shackel, N., Varghese, G., Wade, D., and Israel, Y. (1990). Role of hepatic gamma-glutamyl transferase in the degradation of circulating GSH: Studies in the intact guinea pig perfused liver. Hepatology 11(5), 843-849.
17. Speisky, H., Cassels, B., Lissi, E., and Videla, L. (1991a). Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation. Biochem. Pharmacol. 41, 1575-1581.
18. Speisky, H., Squella, J. A., and Núñez-Vergara, L. J. (1991b). Activity of boldine on rat ileum. Planta Med. 57, 519-522.
19. Speisky, H., Cassels, B. K., Nieto, S., Valenzuela, A., and Nuhez-Vergara, L. (1993). Determination of boldine in plasma by high performance liquid chromatography. J. Chromatog. 612, 315-319.
20. Speisky, H., and Cassels, B. (1994). Boldo and Boldine: An emerging case of drug development. Pharmacol. Res. 29(1), 1-12.
21. Úbeda, A., Montesinos, C., Payá, M., and Alcaraz, M. J. (1993). Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines. Free Rad. Biol. Med. 15, 1-9.
22. Zetler, G. (1988). Anticonvulsivant and antinociceptive effects of apomorphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine. Arch. Int. Pharmacodyn. 296, 255-281.